FDA says review of abortion pill safety will continue into next year

The FDA is studying the safety of mifepristone, a drug used in most abortions in the United States.

It expects to finish the study by mid-December and publish a report by March 2027.

After that, the agency will decide whether to change rules for using the drug.

The review matters because new rules could affect how people get the pill.